Activated eosinophils may potentiate epithelial barrier dysfunction in FD through stimulating the release of proinflammatory mediators, of which tumor necrosis factor (TNF), and interleukin-1β (IL-1β) have been shown to be significantly raised in FD patients (31, 38). This evidence concerns the gene TNF and Fabry disease.